Angelo Sirico

Dr. Angelo Sirico


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SFSonia Fantone
Sonia Fantone
FPFederica Piani
Federica Piani
FOFabiola Olivieri
Fabiola Olivieri
Maria RippoMaria Rippo
Maria Rippo
ASAngelo Sirico
Angelo Sirico
Giovanni TossettaGiovanni Tossetta
Giovanni Tossetta
Ovarian cancer is one of the most dangerous gynecologic cancers worldwide and has a high fatality rate due to diagnosis at an advanced stage of the disease as well as a high recurrence rate due to the occurrence of chemotherapy resistance. In fact, chemoresistance weakens the therapeutic effects, worsening the outcome of this pathology. Solute Carrier Family 7 Member 11 (SLC7A11, also known as xCT) is the functional subunit of the Xc− system, an anionic L-cystine/L-glutamate antiporter expressed on the cell surface. SLC7A11 expression is significantly upregulated in several types of cancers in which it can inhibit ferroptosis and favor cancer cell proliferation, invasion and chemoresistance. SLC7A11 expression is also increased in ovarian cancer tissues, suggesting a possible role of this protein as a therapeutic target. In this review, we provide an overview of the current literature regarding the role of SLC7A11 in ovarian cancer to provide new insights on SLC7A11 modulation and evaluate the potential role of SLC7A11 as a therapeutic target.

14 July 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ASAngelo Sirico
Angelo Sirico
EREsther Diana Rossi
Esther Diana Rossi
VDValentina Anna Degennaro
Valentina Anna Degennaro
VAVincenzo Arena
Vincenzo Arena
ARAlessandro Rizzi
Alessandro Rizzi
ALAntonio Lanzone
Antonio Lanzone

23 August 2021 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
LTlinda tartaglione
linda tartaglione
ESEnrico Di Stasio
Enrico Di Stasio
ASAngelo Sirico
Angelo Sirico
MLMauro Di Leo
Mauro Di Leo
SCSalvatore Caputo
Salvatore Caputo
ALAntonio Lanzone
Antonio Lanzone
Continuous glucose monitoring (CGM) might be an effective tool to improve glycemic control in gestational diabetes mellitus (GDM). Few data are available about its utilization as a diagnostic tool to find potential alterations of glycemia in subjects with normal oral glucose tolerance test (OGTT). In this preliminary prospective real-life observational study, we aimed to analyze the glycemic pattern in normal and gestational diabetes mellitus (GDM) women by continuous glucose monitoring (CGM) in order to detect potential differences between the two groups and glycemic alterations despite a normal OGTT. After the screening for GDM, subjects were connected to a CGM system for seven consecutive days. The areas under the curve of the first 60 minutes after each meal and 60 minutes before breakfast were analyzed. Women with normal OGTT that during CGM showed impaired glycemic values (more than 95 fasting or more than 140 one hour after meals or more than 120 two hours after meals) performed one week of self-monitoring of blood glucose (SMBG). After OGTT, 53 women considered normal and 46 affected by GDM were included. CGM parameters did not show any differences between the two groups with impaired glycemic excursions found in both groups. After CGM period, 33 women with normal OGTT showed abnormal glycemic patterns. These 33 women then performed one week of SMBG. After evaluation of one week of SMBG, 21 required diet therapy and 12 required insulin treatment and were followed until the delivery. An increase in gestational weight gain was observed in normal women with normal OGTT but this was not significant. No significant data were found regarding neonatal outcomes in the two groups of women. In conclusion, CGM use in pregnancy might help to detect glycemic fluctuations in women with normal OGTT, improving their treatment and outcomes.

1 December 2019 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
ASAngelo Sirico
Angelo Sirico
ALAntonio Lanzone
Antonio Lanzone
IMIlenia Mappa
Ilenia Mappa
LSLaura Sarno
Laura Sarno
MSMaciej Słodki
Maciej Słodki
Giuseppe RizzoGiuseppe Rizzo
Giuseppe Rizzo

12 March 2017 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
ASAngelo Sirico
Angelo Sirico
ADA. Diemert
A. Diemert
PGP. Glosemeyer
P. Glosemeyer
KHK. Hecher
K. Hecher
Objectives: To evaluate the relationship between cerebroplacental ratio (CPR) and estimated fetal weight (EFW) in low‐ and high‐risk singleton pregnancies. Furthermore, we evaluated the role of CPR in the prediction of adverse perinatal outcome and whether CPR measurements adjusted for EFW improve its predictive value.Methods: This was a retrospective cohort study including pregnancies in which Doppler investigations of umbilical artery (UA) and fetal middle cerebral artery (MCA) were performed at ≥ 30 weeks' gestation. Pregnancies were allocated to one of three groups according to EFW centile: small‐for‐gestational age (SGA) with EFW < 10th centile, appropriate‐for‐gestational age (AGA) and large‐for‐gestational age (LGA) with EFW > 90th centile. CPR was calculated as the ratio between the UA pulsatility index (PI) and MCA‐PI and converted to CPR multiples of the median (MoMs) according to the three EFW groups. Linear regression analysis was performed to evaluate the relationship between CPR‐MoMs and EFW centiles in low‐risk pregnancies. Furthermore, MoMs of CPR adjusted according to EFW centile (aCPR‐MoMs) were calculated. Adverse perinatal outcome was defined as presence of pathological cardiotocography (CTG) trace, arterial cord blood pH < 7.1, 5‐min Apgar score < 7 and presence of meconium‐stained amniotic fluid (MSAF).Results: A total of 3515 (3016 low risk and 499 high risk) pregnancies, delivered between January 2010 and March 2016, were included. Linear regression analysis revealed a significant positive correlation between EFW centile and CPR‐MoM. Receiver–operating characteristics (ROC) curve analysis showed a significant association between CPR‐MoM and pathological CTG trace (AUC, 0.539; SD, 0.014; P = 0.005) and low Apgar score (AUC, 0.609; SD, 0.041; P = 0.008), but not with low arterial pH or MSAF. There was a significant association between aCPR‐MoM and pathological CTG trace (AUC, 0.540; SD, 0.014; P = 0.003), low arterial cord blood pH (AUC, 0.546; SD, 0.022; P = 0.035) and low Apgar score (AUC, 0.609; SD, 0.044; P = 0.008), but not with MSAF. However, detection rates for adverse perinatal outcomes by CPR‐MoM and aCPR‐MoM were low, ranging from 6.7% to 28.6% for SGA, 12.1% to 22.2% for AGA and 0% to 33.3% for LGA, for a false‐positive rate of 10%. In a subgroup analysis of cases in which ultrasound examination was performed at ≥ 34 weeks of gestation and within 4 weeks of delivery (n = 1439), the ROC curves for aCPR‐MoM were significantly associated with all four outcomes evaluated.Conclusions: CPR‐MoM values are dependent on EFW centiles; therefore, we suggest that CPR‐MoM should be adjusted for EFW centile. However, both CPR‐ and aCPR‐MoM showed a low prediction rate for adverse perinatal outcome. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

1 January 2019 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
ASAngelo Sirico
Angelo Sirico
LSLaura Sarno
Laura Sarno
FZFulvio Zullo
Fulvio Zullo
PMPasquale Martinelli
Pasquale Martinelli
Giuseppe Maria MaruottiGiuseppe Maria Maruotti
Giuseppe Maria Maruotti